Remicade and Asacol drug interactions - from FDA reports


Drug interactions are reported among people who take Remicade and Asacol together. This study is created by eHealthMe based on reports of 2,243 people who take Remicade and Asacol from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Jul, 31, 2018

2,243 people who take Remicade, Asacol are studied.


Number of reports submitted per year:

Remicade and Asacol drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Infusion related reaction
  2. Arthralgia (joint pain)
  3. Dyspnoea (difficult or laboured respiration)
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Pyrexia (fever)
  7. Drug ineffective
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Tremor (trembling or shaking movements in one or more parts of your body)
1 - 6 months:
  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Drug ineffective
  4. Infusion related reaction
  5. Back pain
  6. Dizziness
  7. Hypotension (abnormally low blood pressure)
  8. Feeling hot
  9. Migraine (headache)
  10. Skin disorder (skin disease)
6 - 12 months:
  1. Herpes zoster
  2. Abnormal loss of weight
  3. Diarrhoea
  4. Eating disorder
  5. Oropharyngeal pain
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Weight increased
  8. Body height decreased
  9. Dysphagia (condition in which swallowing is difficult or painful)
  10. Headache (pain in head)
1 - 2 years:
  1. Drug ineffective
  2. Dizziness
  3. Infusion related reaction
  4. Hypertension (high blood pressure)
  5. Nausea (feeling of having an urge to vomit)
  6. Back pain
  7. Burning sensation
  8. Dysgeusia (disorder of the sense of taste)
  9. Electrocardiogram t wave inversion
  10. Erythema (redness of the skin)
2 - 5 years:
  1. Pruritus (severe itching of the skin)
  2. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  3. Rhinalgia (pain in the nose)
  4. Swelling face
  5. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
  6. Abdominal distension
  7. Abdominal pain
  8. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  9. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
  10. Appendix disorder
5 - 10 years:
  1. Viral infection
  2. Abscess (pus)
  3. Abdominal pain upper
  4. Brain mass
  5. Breast cancer
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Colon cancer
  8. Diverticular fistula
  9. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  10. Infusion related reaction
10+ years:
  1. Benign neoplasm (benign (non-cancerous) tumour)
  2. Death
  3. Peritoneal abscess
  4. Pneumonia
  5. Thrombosis (formation of a blood clot inside a blood vessel)
not specified:
  1. Infusion related reaction
  2. Drug ineffective
  3. Arthralgia (joint pain)
  4. Nausea (feeling of having an urge to vomit)
  5. Dyspnoea (difficult or laboured respiration)
  6. Pyrexia (fever)
  7. Fatigue (feeling of tiredness)
  8. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  9. Diarrhoea
  10. Headache (pain in head)
Personalize this study to your gender and age

Most common drug interactions by gender *:

female:
  1. Diarrhoea
  2. Pyrexia (fever)
  3. Headache (pain in head)
  4. Pain
  5. Herpes zoster
  6. Vomiting
  7. Abdominal pain
  8. Erythema (redness of the skin)
  9. Pneumonia
  10. Dizziness
male:
  1. Infusion related reaction
  2. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  3. Diarrhoea
  4. Headache (pain in head)
  5. Fatigue (feeling of tiredness)
  6. Anaemia (lack of blood)
  7. Chest pain
  8. Back pain
  9. Weight decreased
  10. Haematochezia (passage of stools containing blood)
Subscribe to monitor Remicade and Asacol

Most common drug interactions by age *:

0-1:
  1. Trisomy 21 (a chromosomal disorder that results in the presence of an additional third chromosome 21)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Abortion spontaneous (naturally occurring miscarriage)
  4. Low birth weight baby
  5. Maternal drugs affecting foetus (chemical affecting the baby before birth taken by mother)
  6. Neonatal asphyxia (a condition in which an extreme decrease in the concentration of oxygen in the body accompanied by an increase in the concentration of carbon dioxide in neonate)
  7. Premature baby
  8. Congenital anomaly (birth defect)
  9. Ventricular septal defect (a hole in the heart, is a common heart defect that's present at birth (congenital))
  10. Anal atresia (anus is either not present or it is in the wrong place)
2-9:
  1. Infusion related reaction
  2. Anaphylactic reaction (serious allergic reaction)
  3. Death
  4. Nephroblastoma (cancer of the kidneys that typically occurs in children)
  5. Cough
  6. Throat irritation
  7. Acute haemorrhagic oedema of infancy (acute hemorrhagic oedema of childhood)
  8. Henoch-schonlein purpura (inflammation of the blood vessels in the skin and other body organs)
  9. Lipase increased
10-19:
  1. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Lactic acidosis (low ph in body tissues)
  5. Infusion related reaction
  6. Drug ineffective
  7. Anaemia (lack of blood)
  8. Pyrexia (fever)
  9. Dyspnoea (difficult or laboured respiration)
  10. Flushing (the warm, red condition of human skin)
20-29:
  1. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  2. Infusion related reaction
  3. Arthralgia (joint pain)
  4. Weight decreased
  5. Dyspnoea (difficult or laboured respiration)
  6. Abdominal pain
  7. Drug ineffective
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Vomiting
30-39:
  1. Infusion related reaction
  2. Arthralgia (joint pain)
  3. Rash
  4. Pain
  5. Nausea (feeling of having an urge to vomit)
  6. Diarrhoea
  7. Joint swelling
  8. Abdominal pain
  9. Frequent bowel movements
  10. Haematochezia (passage of stools containing blood)
40-49:
  1. Infusion related reaction
  2. Drug ineffective
  3. Erythema (redness of the skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Pyrexia (fever)
  8. Fatigue (feeling of tiredness)
  9. Back pain
  10. Chest pain
50-59:
  1. Infusion related reaction
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Drug ineffective
  5. White blood cell count increased
  6. Pyrexia (fever)
  7. Headache (pain in head)
  8. Herpes zoster
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Chest pain
60+:
  1. Arthralgia (joint pain)
  2. Oropharyngeal pain
  3. Weight increased
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Weight decreased
  6. Oedema peripheral (superficial swelling)
  7. Rash
  8. Fall
  9. Hypotension (abnormally low blood pressure)
  10. Pain
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Remicade and Asacol or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 127,736 users)

Asacol

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. (latest outcomes from Asacol 12,420 users)


Interactions between Remicade and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Asacol and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Remicade and Asacol
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Remicade and Asacol (22,604 reports studied)

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Remicade, Asacol

Recent updates

General studies

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.